Mark Doerr

Mark Doerr is a principal and senior research analyst at Tech Insider covering medical technology companies with a focus on cardiovascular and related therapeutic technology. Mark leverages his prior experience as the director of marketing and business development at a medical device company, along with an extensive network of physician and industry relationships, to provide a unique perspective on the medtech sector. Prior to joining Tech Insider in 2011 he covered medical technology for four years at Craig-Hallum Capital, and has in total 20 years of financial and medtech industry experience.

Market Movers: SIRIUS XM Holding Inc. (NASDAQ:SIRI), Zynga Inc (NASDAQ:ZNGA), Micron Technology (NASDAQ:MU), Groupon Inc (NASDAQ:GRPN)

Sirius XM Holdings Inc. (NASDAQ:SIRI) is now no longer involved in a low-ball buyout attempt by John Malone and Liberty Media Corp. (NASDAQ: LMCA). Last Friday we saw Bank of America Merrill Lynch issue a positive report on the standalone company, and now we have a similar call from Evercore Partners. SIRIUS XM Holding Inc….

Read More

Tech Runners: QUALCOMM (NASDAQ:QCOM), Groupon Inc. (NASDAQ:GRPN), Oracle Corporation (NYSE:ORCL), JA Solar (NASDAQ:JASO)

Qualcomm Inc. (NASDAQ:QCOM) may be have some good news coming in from China, with rumors suggesting that China Mobile has reverted to its initial policy of procuring 4G terminals with support for both TDD- and FDD-LTE. QUALCOMM, Inc. (NASDAQ:QCOM) stock performance was 3.05% in last session and finished the day at $77.02. Traded volume was…

Read More

Biotech Losers: Discovery Laboratories (NASDAQ:DSCO), CEL-SCI Corporation (NYSEMKT:CVM), NewLink Genetics (NASDAQ:NLNK), La Jolla Pharmaceutical (NASDAQ:LJPC)

Discovery Laboratories, Inc. (NASDAQ:DSCO) has been upgraded by TheStreet Ratings from sell to hold. Discovery Laboratories, Inc. (NASDAQ:DSCO) stock performance was -6.01% in last session and finished the day at $2.19. Traded volume was 1,245,476 million shares in the last session and the average volume of the stock remained 589.46 million shares. The beta of…

Read More

Biotech Gainers: Neuralstem (NYSEMKT:CUR), OXiGENE Inc (NASDAQ:OXGN), Idera Pharmaceuticals (NASDAQ:IDRA), Five Prime Therapeutics (NASDAQ:FPRX)

Shares of Neuralstem (NYSEMKT:CUR) , a clinical-stage biopharmaceutical company focused on treating central nervous system disorders through neural stem-cell therapies, advanced as much as 13% after reporting final phase 1 results utilizing NSI-566 in treating amyotrophic lateral sclerosis. Neuralstem, Inc. (NYSEMKT:CUR) stock performance was 12.05% in last session and finished the day at $4.37. Traded…

Read More
FB Nasdaq FB Facebook

Active Stocks Industrial Goods: Cemex SAB (NYSE:CX), General Electric (NYSE:GE), Ballard Power Systems (NASDAQ:BLDP), Capstone Turbine (NASDAQ:CPST)

Andreas Halvorsen’s Viking Global’s new positions in the fourth quarter include Walgreen Co. (WAG), Canadian Pacific Railway (CP), and Cemex SAB de CV (ADR) (NYSE:CX). Cemex SAB de CV (ADR) (NYSE:CX) stock performance was -2.03% in last session and finished the day at $12.06. Traded volume was 35.94million shares in the last session and the…

Read More

Losers on Major News: Facebook Inc (NASDAQ:FB), Google Inc (NASDAQ:GOOG), Tesla Motors Inc (NASDAQ:TSLA), Apple Inc. (NASDAQ:AAPL)

Facebook Inc (NASDAQ:FB) and IBM may make effective business partners assuming IBM helps Facebook’s clientele do a better job of understanding data. Facebook Inc (NASDAQ:FB) stock performance was -1.61% in last session and finished the day at $67.72. Traded volume was 48,075,628 million shares in the last session and the average volume of the stock…

Read More
Home